Prevention of Delirium in Intensive Care by Melatonin

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Treatment of the study is a single daily fixed‐hour (21h) dose of 15 mL of an oral syrup, at one of the 3 following concentrations of melatonin: 0 mg/ml i.e. 0 mg/day (placebo); 0.02 mg/ml, i.e. 0.3 mg/day (low dose of melatonin) or 0.2 mg/ml, i.e. 3 mg/day (high dose of melatonin). The three dosages will be identical in appearance and volume.Treatment will be administered up to Day‐14 (or death or discharge if these occur before Day‐14). Randomization will be stratified by center.
Epistemonikos ID: d6185f31b54f1f73bc98397649f395ca5acc266d
First added on: May 21, 2024